{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:16:48Z","timestamp":1794590208867,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["82102206"],"award-info":[{"award-number":["82102206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hubei Provincial Natural Science Foundation of China","award":["2020CFB371"],"award-info":[{"award-number":["2020CFB371"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Macrophage polarization determines the production of cytokines that fuel the initiation and evolution of rheumatoid arthritis (RA). Thus, modulation of macrophage polarization might represent a potential therapeutic strategy for RA. However, coordinated modulation of macrophages in the synovium and synovial fluid has not been achieved thus far. Herein, we develop a biomimetic ApoA-I mimetic peptide-modified neutrophil membrane-wrapped F127 polymer (R4F-NM@F127) for targeted drug delivery during RA treatment. Due to the high expression of adhesion molecules and chemokine receptors on neutrophils, the neutrophil membrane coating can endow the nanocarrier with synovitis-targeting ability, with subsequent recruitment to the synovial fluid under the chemotactic effects of IL-8. Moreover, R4F peptide modification further endows the nanocarrier with the ability to target the SR-B1 receptor, which is highly expressed on macrophages in the synovium and synovial fluid. Long-term in vivo imaging shows that R4F-NM@F127 preferentially accumulates in inflamed joints and is engulfed by macrophages. After loading of the anti-inflammatory drug celastrol (Cel), R4F-NM@F127-Cel shows a significant reduction in hepatotoxicity, and effectively inhibits synovial inflammation and alleviates joint damage by reprogramming macrophage polarization. Thus, our results highlight the potential of the coordinated targeted modulation of macrophages as a promising therapeutic option for the treatment of RA.<\/jats:p>","DOI":"10.1186\/s12951-023-01773-x","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T05:04:20Z","timestamp":1673586260000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Peptide-anchored neutrophil membrane-coated biomimetic nanodrug for targeted treatment of rheumatoid arthritis"],"prefix":"10.1186","volume":"21","author":[{"given":"Ni","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoye","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqin","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"1773_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","volume":"15","author":"Z Chen","year":"2019","unstructured":"Chen Z, Bozec A, Ramming A, Schett G. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol. 2019;15:9\u201317.","journal-title":"Nat Rev Rheumatol"},{"key":"1773_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.biopha.2017.05.055","volume":"92","author":"J Alam","year":"2017","unstructured":"Alam J, Jantan I, Bukhari SNA. Rheumatoid arthritis: recent advances on its etiology, role of cytokines and pharmacotherapy. Biomed Pharmacother. 2017;92:615\u201333.","journal-title":"Biomed Pharmacother"},{"key":"1773_CR3","doi-asserted-by":"publisher","first-page":"102369","DOI":"10.1016\/j.autrev.2019.102369","volume":"18","author":"P Di Benedetto","year":"2019","unstructured":"Di Benedetto P, Ruscitti P, Vadasz Z, Toubi E, Giacomelli R. Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases. Autoimmun Rev. 2019;18:102369.","journal-title":"Autoimmun Rev"},{"key":"1773_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bcp.2019.03.029","volume":"165","author":"E Siouti","year":"2019","unstructured":"Siouti E, Andreakos E. The many facets of macrophages in rheumatoid arthritis. Biochem Pharmacol. 2019;165:152\u201369.","journal-title":"Biochem Pharmacol"},{"key":"1773_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrrheum.2016.91","volume":"12","author":"IA Udalova","year":"2016","unstructured":"Udalova IA, Mantovani A, Feldmann M. Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol. 2016;12:472\u201385.","journal-title":"Nat Rev Rheumatol"},{"key":"1773_CR6","doi-asserted-by":"publisher","first-page":"114368","DOI":"10.1016\/j.jep.2021.114368","volume":"279","author":"Y Wang","year":"2021","unstructured":"Wang Y, Chen S, Du K, Liang C, Wang S, Owusu Boadi E, Li J, Pang X, He J, Chang YX. Traditional herbal medicine: therapeutic potential in rheumatoid arthritis. J Ethnopharmacol. 2021;279:114368.","journal-title":"J Ethnopharmacol"},{"key":"1773_CR7","doi-asserted-by":"publisher","first-page":"945129","DOI":"10.3389\/fimmu.2022.945129","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Wang Z, Qian H, Tao W, Zhang Y, Hu C, Mao W, Guo Q. Natural medicines of targeted rheumatoid arthritis and its action mechanism. Front Immunol. 2022;13:945129.","journal-title":"Front Immunol"},{"key":"1773_CR8","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.1021\/acs.nanolett.0c03279","volume":"20","author":"L An","year":"2020","unstructured":"An L, Li Z, Shi L, Wang L, Wang Y, Jin L, Shuai X, Li J. Inflammation-targeted celastrol nanodrug attenuates collagen-Induced arthritis through NF-kappaB and notch1 pathways. Nano Lett. 2020;20:7728\u201336.","journal-title":"Nano Lett"},{"key":"1773_CR9","doi-asserted-by":"publisher","first-page":"121578","DOI":"10.1016\/j.biomaterials.2022.121578","volume":"286","author":"H Kim","year":"2022","unstructured":"Kim H, Back JH, Han G, Lee SJ, Park YE, Gu MB, Yang Y, Lee JE, Kim SH. Extracellular vesicle-guided in situ reprogramming of synovial macrophages for the treatment of rheumatoid arthritis. Biomaterials. 2022;286:121578.","journal-title":"Biomaterials"},{"key":"1773_CR10","doi-asserted-by":"publisher","first-page":"120390","DOI":"10.1016\/j.biomaterials.2020.120390","volume":"264","author":"Y Yang","year":"2021","unstructured":"Yang Y, Guo L, Wang Z, Liu P, Liu X, Ding J, Zhou W. Targeted silver nanoparticles for rheumatoid arthritis therapy via macrophage apoptosis and re-polarization. Biomaterials. 2021;264:120390.","journal-title":"Biomaterials"},{"key":"1773_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-020-00675-6","volume":"18","author":"F Yan","year":"2020","unstructured":"Yan F, Zhong Z, Wang Y, Feng Y, Mei Z, Li H, Chen X, Cai L, Li C. Exosome-based biomimetic nanoparticles targeted to inflamed joints for enhanced treatment of rheumatoid arthritis. J Nanobiotechnol. 2020;18:1\u201315.","journal-title":"J Nanobiotechnol"},{"key":"1773_CR12","doi-asserted-by":"publisher","first-page":"120296","DOI":"10.1016\/j.biomaterials.2020.120296","volume":"258","author":"T Gong","year":"2020","unstructured":"Gong T, Tan T, Zhang P, Li H, Deng C, Huang Y, Gong T, Zhang Z. Palmitic acid-modified bovine serum albumin nanoparticles target scavenger receptor-A on activated macrophages to treat rheumatoid arthritis. Biomaterials. 2020;258:120296.","journal-title":"Biomaterials"},{"key":"1773_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41584-018-0123-4","volume":"15","author":"IA Jones","year":"2019","unstructured":"Jones IA, Togashi R, Wilson ML, Heckmann N, Vangsness CT Jr. Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol. 2019;15:77\u201390.","journal-title":"Nat Rev Rheumatol"},{"key":"1773_CR14","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1039\/C7BM00254H","volume":"5","author":"Q Wang","year":"2017","unstructured":"Wang Q, Sun X. Recent advances in nanomedicines for the treatment of rheumatoid arthritis. Biomater Sci. 2017;5:1407\u201320.","journal-title":"Biomater Sci"},{"key":"1773_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrrheum.2014.80","volume":"10","author":"HL Wright","year":"2014","unstructured":"Wright HL, Moots RJ, Edwards SW. The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol. 2014;10:593\u2013601.","journal-title":"Nat Rev Rheumatol"},{"key":"1773_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13578-018-0266-7","volume":"9","author":"J Jeong","year":"2019","unstructured":"Jeong J, Kim YJ, Lee DY, Moon BG, Sohn KY, Yoon SY, Kim JW. 1-Palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (PLAG) attenuates gemcitabine-induced neutrophil extravasation. Cell Biosci. 2019;9:4.","journal-title":"Cell Biosci"},{"key":"1773_CR17","doi-asserted-by":"publisher","first-page":"165920","DOI":"10.1016\/j.bbadis.2020.165920","volume":"1866","author":"LM Zhu","year":"2020","unstructured":"Zhu LM, Zeng D, Lei XC, Huang J, Deng YF, Ji YB, Liu J, Dai FF, Li YZ, Shi DD, et al. KLF2 regulates neutrophil migration by modulating CXCR1 and CXCR2 in asthma. Biochim Biophys Acta Mol Basis Dis. 2020;1866:165920.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"1773_CR18","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1002\/eji.202049029","volume":"51","author":"A Teijeira","year":"2021","unstructured":"Teijeira A, Garasa S, Ochoa MDC, Cirella A, Olivera I, Glez-Vaz J, Andueza MP, Migueliz I, Alvarez M, Rodriguez-Ruiz ME, et al. Differential Interleukin-8 thresholds for chemotaxis and netosis in human neutrophils. Eur J Immunol. 2021;51:2274\u201380.","journal-title":"Eur J Immunol"},{"key":"1773_CR19","doi-asserted-by":"publisher","first-page":"e1801674","DOI":"10.1002\/smll.201801674","volume":"14","author":"Y Han","year":"2018","unstructured":"Han Y, Zhao R, Xu F. Neutrophil-based delivery systems for nanotherapeutics. Small. 2018;14:e1801674.","journal-title":"Small"},{"issue":"34","key":"1773_CR20","doi-asserted-by":"publisher","first-page":"2102912","DOI":"10.1002\/adfm.202102912","volume":"31","author":"YH Bi","year":"2021","unstructured":"Bi YH, Duan WX, Chen J, You T, Li SY, Jiang W, Li M, Wang G, Pan XY, Wu J, et al. Neutrophil decoys with anti-inflammatory and anti-oxidative properties reduce secondary Spinal cord injury and improve neurological functional recovery. Adv Funct Mater. 2021;31(34):2102912.","journal-title":"Adv Funct Mater"},{"issue":"7","key":"1773_CR21","doi-asserted-by":"publisher","first-page":"2011349","DOI":"10.1002\/adhm.202101349","volume":"11","author":"D Wang","year":"2022","unstructured":"Wang D, Wang SY, Zhou ZD, Bai D, Zhang QZ, Ai XZ, Gao WW, Zhang LF. White blood cell membrane-coated nanoparticles: recent development and medical applications. Adv Healthcare Mater. 2022;11(7):2011349.","journal-title":"Adv Healthcare Mater"},{"key":"1773_CR22","doi-asserted-by":"publisher","first-page":"119987","DOI":"10.1016\/j.biomaterials.2020.119987","volume":"245","author":"LS Lu","year":"2020","unstructured":"Lu LS, Qi SH, Chen YZ, Luo HM, Huang SL, Yu X, Luo QM, Zhang ZH. Targeted immunomodulation of inflammatory monocytes across the blood-brain barrier by curcumin-loaded nanoparticles delays the progression of experimental autoimmune encephalomyelitis. Biomaterials. 2020;245:119987.","journal-title":"Biomaterials"},{"key":"1773_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/cei.13218","volume":"195","author":"J Lin","year":"2019","unstructured":"Lin J, He Y, Wang B, Xun Z, Chen S, Zeng Z, Ou Q. Blocking of YY1 reduce neutrophil infiltration by inhibiting IL-8 production via the PI3K-Akt-mTOR signaling pathway in rheumatoid arthritis. Clin Exp Immunol. 2019;195:226\u201336.","journal-title":"Clin Exp Immunol"},{"key":"1773_CR24","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s41584-022-00790-8","volume":"18","author":"M Kurowska-Stolarska","year":"2022","unstructured":"Kurowska-Stolarska M, Alivernini S. Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission. Nat Rev Rheumatol. 2022;18:384\u201397.","journal-title":"Nat Rev Rheumatol"},{"key":"1773_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1126\/scitranslmed.aac5608","volume":"7","author":"SE Headland","year":"2015","unstructured":"Headland SE, Jones HR, Norling LV, Kim A, Souza PR, Corsiero E, Gil CD, Nerviani A, Dell\u2019Accio F, Pitzalis C, et al. Neutrophil-derived microvesicles enter cartilage and protect the joint in inflammatory arthritis. Sci Transl Med. 2015;7:315.","journal-title":"Sci Transl Med"},{"key":"1773_CR26","doi-asserted-by":"publisher","first-page":"e12854","DOI":"10.1111\/cpr.12854","volume":"53","author":"X Yang","year":"2020","unstructured":"Yang X, Chang Y, Wei W. Emerging role of targeting macrophages in rheumatoid arthritis: focus on polarization, metabolism and apoptosis. Cell Prolif. 2020;53:e12854.","journal-title":"Cell Prolif"},{"key":"1773_CR27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.jconrel.2022.01.029","volume":"343","author":"XS Liu","year":"2022","unstructured":"Liu XS, Guo RR, Huo SC, Chen H, Song QX, Jiang G, Yu Y, Huang JL, Xie SW, Gao XL, Lu LJ. CaP-based anti-inflammatory HIF-1 alpha siRNA-encapsulating nanoparticle for rheumatoid arthritis therapy. J Controlled Release. 2022;343:314\u201325.","journal-title":"J Controlled Release"},{"key":"1773_CR28","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00011-020-01327-z","volume":"69","author":"K Feng","year":"2020","unstructured":"Feng K, Chen H, Xu C. Chondro-protective effects of celastrol on osteoarthritis through autophagy activation and NF-kappaB signaling pathway inhibition. Inflamm Res. 2020;69:385\u2013400.","journal-title":"Inflamm Res"},{"key":"1773_CR29","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nri3495","volume":"13","author":"JSC Arthur","year":"2013","unstructured":"Arthur JSC, Ley SC. Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol. 2013;13:679\u201392.","journal-title":"Nat Rev Immunol"},{"key":"1773_CR30","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1080\/10717544.2022.2089295","volume":"29","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Gao Z, Chao S, Lu W, Zhang P. Transdermal delivery of inflammatory factors regulated drugs for rheumatoid arthritis. Drug Deliv. 2022;29:1934\u201350.","journal-title":"Drug Deliv"},{"key":"1773_CR31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1080\/10717544.2022.2032482","volume":"29","author":"C Yu","year":"2022","unstructured":"Yu C, Liu H, Guo C, Chen Q, Su Y, Guo H, Hou X, Zhao F, Fan H, Xu H, et al. Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis. Drug Deliv. 2022;29:454\u201365.","journal-title":"Drug Deliv"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-01773-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01773-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T05:05:13Z","timestamp":1673586313000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-01773-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1773"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-01773-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"assertion":[{"value":"27 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal studies were conducted in compliance with protocols that had been approved by the Ethics Committee of China Three Gorges University and in compliance with the experimental guidelines of the National Institutes of Health on the care and use of animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors concur with the submission and publication of this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}